国际肿瘤学杂志 ›› 2015, Vol. 42 ›› Issue (5): 374-376.doi: 10.3760/cma.j.issn.1673422X.2015.05.015

• 综述 • 上一篇    下一篇

甲状腺微小癌外科治疗进展

  

  1. 安徽省蚌埠医学院第一附属医院肿瘤外三科
  • 出版日期:2015-05-08 发布日期:2015-05-12
  • 通讯作者: 李德群 lidequn8888@163.com

Surgical treatment of thyroid microcarcinoma

  1. Third Department of Oncological Surgery, First Affiliated Hospital of Bengbu Medical College
  • Online:2015-05-08 Published:2015-05-12
  • Contact: Li Dequn lidequn8888@163.com

摘要: 甲状腺微小癌(TMC)发病隐匿、病变直径小、临床症状不显著、病情进展缓慢。研究认为年龄≥45岁和≤15岁、男性、病灶≥5 mm、淋巴结转移者预后较差,应积极手术治疗。手术切除范围应考虑患者的临床资料,在完整切除病灶的基础上,尽量保留正常腺体。对颈部淋巴结转移患者可行淋巴结清扫术,淋巴结阴性者可行预防性中区淋巴结清扫。降低肿瘤复发转移风险,提高患者带瘤生存率与改善患者生命质量,成为TMC患者治疗随访的首要目标,对TMC的规范化治疗起着至关重要的作用。

Abstract: For thyroid microcarcinoma (TMC), the incidence is not obvious, the lesion is small, the symptoms are not distinctive and the progression is slow. Studies suggest that patients with the age over 45 years or below 15 years old, male, lesion over 5 mm and lymph node metastasis have poor prognosis and active operation treatment is needed. When in operation, the excision extension should take clinical data into consideration, and complete resection of the lesions and preservation of the normal tissue as much as possible should be done. For the patients with lymph node metastasis, lymph node dissection is feasible, and the central lymph node dissection is applicable for the negative lymph nodes. Reduce the risk of recurrence and metastasis, increase the survival rate of patients with tumor and  improve the quality of life, become the prime target of the follow up, in which the standardized treatment of TMC plays a vital role.